CAR T-cell therapy is a highly promising treatment strategy for tumors, but is associated with life-threatening side effects. Researchers at EPFL, UNIL and CHUV have developed a new way to “switch off” the therapy when a cancer patient’s life is in danger, paving the way for safer immunotherapy approaches to target solid tumors.
Media properties
- Themes
- Research and Tech Transfer , Cancer, STI, Research and Tech Transfer
- Copyright
- EPFL - Alain Herzog
- Licence
- CC0 Licence
- Shooting date
- Feb. 3, 2020
- Album
- Designing an emergency stop switch for immunotherapies
Share on
